JP2011006480A5 - - Google Patents

Download PDF

Info

Publication number
JP2011006480A5
JP2011006480A5 JP2010228356A JP2010228356A JP2011006480A5 JP 2011006480 A5 JP2011006480 A5 JP 2011006480A5 JP 2010228356 A JP2010228356 A JP 2010228356A JP 2010228356 A JP2010228356 A JP 2010228356A JP 2011006480 A5 JP2011006480 A5 JP 2011006480A5
Authority
JP
Japan
Prior art keywords
group
compound
cancer
lower alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010228356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011006480A (ja
JP5679757B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011006480A publication Critical patent/JP2011006480A/ja
Publication of JP2011006480A5 publication Critical patent/JP2011006480A5/ja
Application granted granted Critical
Publication of JP5679757B2 publication Critical patent/JP5679757B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2010228356A 2002-11-07 2010-10-08 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法 Expired - Fee Related JP5679757B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42535202P 2002-11-07 2002-11-07
US60/425,352 2002-11-07
US47374303P 2003-05-27 2003-05-27
US60/473,743 2003-05-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005507102A Division JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013147528A Division JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Publications (3)

Publication Number Publication Date
JP2011006480A JP2011006480A (ja) 2011-01-13
JP2011006480A5 true JP2011006480A5 (cg-RX-API-DMAC7.html) 2011-11-17
JP5679757B2 JP5679757B2 (ja) 2015-03-04

Family

ID=32314587

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2005507102A Expired - Fee Related JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
JP2010228356A Expired - Fee Related JP5679757B2 (ja) 2002-11-07 2010-10-08 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法
JP2013147528A Pending JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005507102A Expired - Fee Related JP4641941B2 (ja) 2002-11-07 2003-11-07 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013147528A Pending JP2013213054A (ja) 2002-11-07 2013-07-16 トランス−9,10−デヒドロエポチロンcおよびd、それらのアナログ、ならびにそれらを作製する方法

Country Status (14)

Country Link
US (2) US20040152708A1 (cg-RX-API-DMAC7.html)
EP (3) EP2135867B1 (cg-RX-API-DMAC7.html)
JP (3) JP4641941B2 (cg-RX-API-DMAC7.html)
KR (2) KR100966667B1 (cg-RX-API-DMAC7.html)
AT (1) ATE452888T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003291337B2 (cg-RX-API-DMAC7.html)
CA (1) CA2505368C (cg-RX-API-DMAC7.html)
CY (1) CY1110295T1 (cg-RX-API-DMAC7.html)
DE (1) DE60330703D1 (cg-RX-API-DMAC7.html)
DK (1) DK1562941T3 (cg-RX-API-DMAC7.html)
ES (2) ES2436296T3 (cg-RX-API-DMAC7.html)
PT (1) PT1562941E (cg-RX-API-DMAC7.html)
SI (1) SI1562941T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004043954A2 (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273083C (en) 1996-12-03 2012-09-18 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
US7384964B2 (en) * 2002-08-23 2008-06-10 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
DK1767535T3 (da) 2002-08-23 2010-04-12 Sloan Kettering Inst Cancer Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CN1330648C (zh) * 2002-11-07 2007-08-08 科桑生物科学公司 反式-9,10-脱氢埃坡霉素c和d,其类似物以及制备这些化合物的方法
SI1562941T1 (sl) * 2002-11-07 2010-05-31 Kosan Biosciences Inc Trans dehidroepotilon c in d njihovi analogi in postopek za izdelavo le teh
US20050002983A1 (en) * 2003-03-28 2005-01-06 Johnson Robert G. Devices, methods, and compositions to prevent restenosis
WO2005034964A1 (en) * 2003-10-09 2005-04-21 Kosan Biosciences, Inc. Therapeutic formulations
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
CN105061577A (zh) * 2006-12-14 2015-11-18 爱勒让治疗公司 双巯基大环化系统
US7981998B2 (en) * 2006-12-14 2011-07-19 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
CN104086641A (zh) * 2007-02-23 2014-10-08 爱勒让治疗公司 三唑大环系统
CA2682174C (en) 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
US8030503B2 (en) 2007-05-11 2011-10-04 Kosan Biosciences Incorporated Process for the preparation of epothilones
US7955824B2 (en) * 2007-05-11 2011-06-07 Kosan Biosciences Incorporated Methods of making epothilones
US9175047B2 (en) 2009-01-14 2015-11-03 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
AU2010298338A1 (en) 2009-09-22 2012-04-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2012021875A1 (en) 2010-08-13 2012-02-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles with triazole linkers
CN108929375A (zh) 2011-10-18 2018-12-04 爱勒让治疗公司 拟肽大环化合物
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN112500466B (zh) 2012-02-15 2022-05-03 艾瑞朗医疗公司 拟肽大环化合物
CA2776178A1 (en) 2012-04-05 2013-10-05 Hydro-Quebec Ionic compounds
CN104812384B (zh) 2012-11-01 2020-09-18 爱勒让治疗公司 二取代的氨基酸及其制备和使用方法
EP3197478A4 (en) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10905739B2 (en) 2014-09-24 2021-02-02 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
SG11201707750YA (en) 2015-03-20 2017-10-30 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN108368161A (zh) 2015-09-10 2018-08-03 艾瑞朗医疗公司 作为mcl-1调节剂的拟肽大环化合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148223T3 (es) 1992-03-23 2000-10-16 Univ Georgetown Taxol encapsulado en liposomas y metodo para su uso.
WO1994026254A1 (en) 1993-05-17 1994-11-24 The Liposome Company, Inc. Incorporation of taxol into liposomes and gels
US5415869A (en) 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5662883A (en) 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5534270A (en) 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
WO1997033552A1 (en) 1996-03-12 1997-09-18 Pg-Txl Company, L.P. Water soluble paclitaxel prodrugs
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
PL201329B1 (pl) 1998-02-05 2009-03-31 Novartis Ag Preparat farmaceutyczny w postaci koncentratu infuzyjnego
US6596875B2 (en) * 2000-02-07 2003-07-22 James David White Method for synthesizing epothilones and epothilone analogs
DE19954229A1 (de) * 1999-11-04 2001-05-10 Schering Ag Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
DE19907480A1 (de) * 1999-02-11 2000-08-17 Schering Ag Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
MXPA01011981A (es) 1999-05-24 2003-09-04 Sonus Pharma Inc Vehiculo de emulsion para farmacos poco solubles.
GB9918429D0 (en) 1999-08-04 1999-10-06 Novartis Ag Organic compounds
CN100480389C (zh) 2000-04-28 2009-04-22 科塞生物科学有限公司 聚酮化合物的制备
AU2001266583A1 (en) * 2000-05-26 2001-12-11 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
US6906188B2 (en) * 2001-04-30 2005-06-14 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Method for synthesizing epothilones and epothilone analogs
US20030176368A1 (en) * 2001-09-06 2003-09-18 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en) * 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6921769B2 (en) * 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
DK1767535T3 (da) * 2002-08-23 2010-04-12 Sloan Kettering Inst Cancer Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
SI1562941T1 (sl) * 2002-11-07 2010-05-31 Kosan Biosciences Inc Trans dehidroepotilon c in d njihovi analogi in postopek za izdelavo le teh

Similar Documents

Publication Publication Date Title
JP2011006480A5 (cg-RX-API-DMAC7.html)
KR102279999B1 (ko) 선택적 에스트로겐 수용체 분해제로서의 벤조티오펜 유도체 및 그의 조성물
JP2013513613A5 (cg-RX-API-DMAC7.html)
JP2013508279A5 (cg-RX-API-DMAC7.html)
JP2012530758A5 (cg-RX-API-DMAC7.html)
JP2017537949A5 (cg-RX-API-DMAC7.html)
JP2011526924A5 (cg-RX-API-DMAC7.html)
JP2013532652A5 (cg-RX-API-DMAC7.html)
JP2012506872A5 (cg-RX-API-DMAC7.html)
JP2010523522A5 (cg-RX-API-DMAC7.html)
JP2014518266A5 (cg-RX-API-DMAC7.html)
JP2013542261A5 (cg-RX-API-DMAC7.html)
JP2011507896A5 (cg-RX-API-DMAC7.html)
JP2009507909A5 (cg-RX-API-DMAC7.html)
JP2006506443A5 (cg-RX-API-DMAC7.html)
JP2010241830A5 (cg-RX-API-DMAC7.html)
TW200736234A (en) Chemical compounds
JP2010518094A5 (cg-RX-API-DMAC7.html)
JP2011521911A5 (cg-RX-API-DMAC7.html)
JP2014500235A5 (cg-RX-API-DMAC7.html)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2011509949A5 (cg-RX-API-DMAC7.html)
JP2014505107A5 (cg-RX-API-DMAC7.html)
JP2015508092A5 (cg-RX-API-DMAC7.html)
JP2013514980A5 (cg-RX-API-DMAC7.html)